Leadership Team

Brian Concannon joined Haemonetics in 2003 as President of the Patient Division. He was promoted to President of Global Markets in 2006 and then to Chief Operating Officer in 2007. In April 2009, he was promoted to President and Chief Executive Officer, and elected to the Haemonetics Board of Directors. Immediately prior to joining Haemonetics, Mr. Concannon was President of the Northeast Region at Cardinal Health Medical Products and Services where he was employed since 1998. From 1985 to 1998, he was employed by American Hospital Supply Corporation, Baxter Healthcare Corporation, and Allegiance Healthcare in a series of sales and operations management positions of increasing responsibility.

Mikael Gordon joined Haemonetics in 2007 as President of Europe, and was promoted to President of Global Markets in February 2009. Prior to joining Haemonetics, Mr. Gordon was Regional Executive Manager of North and West Europe for GE Healthcare Clinical Systems. From 1997 to 2007, he held various executive positions as Vice President of IT, Vice President of Laboratory Products, Vice President of Strategic Planning, and Vice President of Global Sales within Amersham Biosciences until the company was acquired by General  More

Peter Allen joined Haemonetics in 2003 as President of the Donor Division. In March 2008, Mr. Allen was appointed Chief Marketing Officer. In October 2011, he was promoted to President of Global Plasma. Prior to joining Haemonetics, Mr. Allen was Vice President of The Aethena Group, a private equity firm providing services to the global healthcare industry. From 1998 to 2001, he held various positions including Vice President of Sales and the Oncology Business at Syncor International, a provider of radiopharmaceutical and comprehensive medical imaging services.  More

Michael Kelly joined Haemonetics in 2010 as President of North America and the Global Plasma business. In 2011, his responsibilities expanded to include the Software and Global Marketing functions and his title changed to President of North America. Prior to joining Haemonetics, Mr. Kelly was Senior Vice President and General Manager of Infection Prevention for CareFusion Corporation. He spent several years with Cardinal Health in a variety of general management, marketing, business development, and sales positions. Mr. Kelly began his career with Baxter Healthcare as a Sales Representative in 1991.

Christopher Lindop joined Haemonetics in January of 2007 as Chief Financial Officer. In 2007, Mr. Lindop assumed responsibility for business development. Prior to joining Haemonetics, he was Chief Financial Officer at Inverness Medical Innovations, a rapidly growing global developer of advanced consumer and professional diagnostic products from 2003 to 2006. Prior to this, Mr. Lindop was a Partner in the Boston offices of Ernst & Young LLP and Arthur Andersen LLP.

Sandra Jesse joined Haemonetics as Vice President, Chief Legal Officer in September 2011, and is responsible for the company’s world-wide Legal, Compliance, Corporate Audit and Controls, and Environmental Health and Safety groups. Ms. Jesse was previously the Executive Vice President and Chief Legal Officer of Blue Cross Blue Shield of Massachusetts, a Partner in the Boston law firm of Choate, Hall and Stewart, and Press Secretary for United States Congressman, Lee Hamilton. She has served on a number of boards and is presently the Chair of the New England Foundation. Ms. Jesse is a former President of the Boston Bar Foundation.

Warren Nighan joined Haemonetics in November of 2010 as Vice President of Worldwide Quality & Regulatory Affairs. Mr. Nighan previously served as Vice President of Quality & Regulatory for St. Jude Medical in Minneapolis, Minnesota. Prior to that, he held numerous roles of increasing responsibility in quality and regulatory affairs at Covidien, Tyco Healthcare, and Kendall Healthcare. Mr. Nighan holds a bachelor’s degree in nursing from Northeastern University.

Dr. Jonathan White joined Haemonetics in 2008 as Vice President of Research and Development.  Dr. White joined Haemonetics from Pfizer where he held a number of roles including Chief Information Officer. He previously worked at McKinsey and Company in New York. Dr. White is a Fellow of the Royal College of Surgery in England.

Joseph Forish joined Haemonetics in 2005 as Vice President of Human Resources. Prior to joining Haemonetics, Mr. Forish held various global human resources leadership roles, including Vice President of Corporate Human Resources for the Rohm and Haas Company, an $8 billion specialty materials company. Prior to that, he was Vice President of Human Resources for the ConvaTec Division of the Bristol Myers Squibb Company.